KER-065: Clinical Trials

1 trial of KER-065, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow KER-065: new trials by email Literature Review of KER-065 trials Research Report on KER-065

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
KER-065 - Duchenne Muscular Dystrophy
Phase 2RecruitingKeros Therapeutics, Inc.362026-09-252026-11-04

Conditions studied

Muscular Dystrophy, Duchenne (1)

Sponsors

Keros Therapeutics, Inc. (1)

Countries

Georgia (1)  ·  New Zealand (1)